… i-AML is often considered a separate biological entity when … The chromosome translocation
t(8,16)(p11;p13) that generates … acute leukemia in early childhood gathers groups of different …

… myeloid sarcoma (MS) of the skin has a variable clinical … FoundationOne CDx testing
revealed at (8;22) (p11; q13) … or t (8;16) in pediatric AML is a rare but recurrent and distinct …

… A distinctive feature of this condition is occurrence of spontaneous remission (SR) in some
… congenital t(8;16)(p11.2;p13.3) AML and mild clinical symptoms. Twelve cases of congenital …

… Pediatric t(8;16)(p11;p13) AML is a rare clinical entity associated … distinct clinical and
biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AMLstudy group…

… Medical record review provided pertinent clinical information. … eosinophilic and vacuolated/clear
cytoplasm and smaller cells … translocation t(8;16)(p11; p13) of acute myeloid leukaemia …

… AML with translocation t(8;16)(p11;p13) is a very rare abnormality (< 1% in adults and
children, … Clinically, AML with t(8;16) is commonly associated with extramedullary disease and …

… cohort of pediatric acute myeloid leukemia, myeloid leukemia of … resolve in pediatric AML
so far is AML with t(8;16) [5]. … families for giving their consent for reporting the clinical data. …

… -old mother with a past medical history of a benign pancreatic … leukemia gene (11q23) with
translocation t(8;16) (p11.2;p13.3… of neonatal leukemia (<1% of childhood cancer) and can be …

… Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity:
a collaborative study by the InternationalBerlin-Frankfurt-Munster AML-study group. Blood. …

… abnormality patterns t(1;19)(q23;p13), t(4;11)(q21;q23), t(9;22)… myeloid leukemias, it is quite
clear that DS-AML is clinically … reported to the International Berlin-Frankfurt-Münster (iBFM) …